FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
Atsushi Okato(National Institutes for Quantum Science and Technology), William Y. Kim(University of North Carolina at Chapel Hill)
Cited by 27
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
|New England Journal of Medicine|2024|145
Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
|Molecular Cell|2020|75
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
|Journal of Clinical Investigation|2014|66
Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma
|International Journal of Molecular Sciences|2017|61